Advertisement
Screener

Caribou Biosciences, Inc. (CRBU) Other

Caribou Biosciences, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market.
  • 2025-03-10: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market.
  • 2024-03-11: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market.
  • 2023-03-09: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market.
FiledFormItemAs filed
2026-03-0510-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2025-03-1010-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2024-03-1110-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2023-03-0910-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2022-11-0810-QSmaller reporting companyNo
2022-08-0910-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2022-08-0910-QSmaller reporting companyNo
2022-05-0910-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2022-05-0910-QSmaller reporting companyNo
2022-03-2110-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2022-03-2110-KSmaller reporting companyNo
2021-11-0910-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2021-11-0910-QSmaller reporting companyNo
2021-09-0210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBU · The Nasdaq Global Select Market
2021-09-0210-QSmaller reporting companyNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22